Clinical trialNCT04356859CompletedInterventional

The Acute Burn ResUscitation Multicenter Prospective Trial

SponsorAmerican Burn AssociationEnrollment101Burn Injury

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a prospective randomized multi-center study which will compare acute fluid resuscitation using a colloid strategy (LR + 5% Albumin) to a crystalloid strategy (LR alone), in adults with an acute burn involving at least 25% of their total body surface area.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

David G Greenhalgh, MD
UC Davis Health
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

University of Alberta
Edmonton, Alberta, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada

United States

Arizona Burn Center Valleywise Health
Phoenix, Arizona, United States
University of California Davis, Regional Burn Center
Sacramento, California, United States
Torrance Memorial
Torrance, California, United States
University of Florida Health
Gainesville, Florida, United States
University of Miami Health System
Miami, Florida, United States
University of South Florida
Tampa, Florida, United States
Loyola Medicine
Maywood, Illinois, United States
University of Iowa Healthcare
Iowa City, Iowa, United States
University of Kansas Health System
Kansas City, Kansas, United States
Ascension Via Christi St. Francis
Wichita, Kansas, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Hennepin Healthcare
Minneapolis, Minnesota, United States
Cooperman Barnabas Medical Center
Livingston, New Jersey, United States
Erie County Medical Center
Buffalo, New York, United States
Westchester Medical Center Health Network
Valhalla, New York, United States
Atrium Health Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States
University of Cincinnati College of Medicine
Cincinnati, Ohio, United States
Metrohealth Medical Center
Cleveland, Ohio, United States
Legacy Health
Portland, Oregon, United States
West Penn Hospital
Pittsburgh, Pennsylvania, United States
the University of Tennessee Health Science Center
Memphis, Tennessee, United States
University of Utah Health
Salt Lake City, Utah, United States
Regional Burn Center at Harborview
Seattle, Washington, United States
University of Wisconsin Health
Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Albumin human, USP →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 22 Apr 2021
Primary completion: 29 Sept 2025
Completion: 29 Sept 2025
Last update posted: 20 May 2026
Registered enrollment: 101
Registry id: NCT04356859

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.